Johnson & Johnson Coronavirus vaccine illustration

Dado Ruvic | Reuters

Johnson & Johnson hasn’t manufactured a lot of doses of its single-shot Covid-19 vaccine ahead of its regulatory clearance expected later this month.

The administration has learned in the last couple of weeks that J&J will only have “a few million” doses ready when the vaccine is likely authorized by the Food and Drug Administration, Jeff Zients, Biden’s Covid czar, told reporters Wednesday during a White House news briefing on the pandemic. 

This is a developing story. Please check back for updates.



READ SOURCE

READ  WHO says the record number of coronavirus cases isn't just because of more testing

LEAVE A REPLY

Please enter your comment!
Please enter your name here